Movatterモバイル変換


[0]ホーム

URL:


WO1997036151A1 - Device for displaying parameters in such a way that a fast evaluation of these parameters can be obtained - Google Patents

Device for displaying parameters in such a way that a fast evaluation of these parameters can be obtained
Download PDF

Info

Publication number
WO1997036151A1
WO1997036151A1PCT/IT1997/000062IT9700062WWO9736151A1WO 1997036151 A1WO1997036151 A1WO 1997036151A1IT 9700062 WIT9700062 WIT 9700062WWO 9736151 A1WO9736151 A1WO 9736151A1
Authority
WO
WIPO (PCT)
Prior art keywords
parameter
rectangle
values
parameters
model
Prior art date
Application number
PCT/IT1997/000062
Other languages
German (de)
French (fr)
Inventor
Efstathios Varvarigos
Original Assignee
Efstathios Varvarigos
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Efstathios VarvarigosfiledCriticalEfstathios Varvarigos
Priority to AU19391/97ApriorityCriticalpatent/AU1939197A/en
Priority to EP97907270Aprioritypatent/EP0890082A1/en
Publication of WO1997036151A1publicationCriticalpatent/WO1997036151A1/en

Links

Classifications

Definitions

Landscapes

Abstract

This model includes parameters measured and evaluated by different measure units and scales of values, reported on different graduated scales (13). Graduated scales are adapted to a rectangle (horizontal minor sides, vertical major sides) in a way that inferior and superior limits of normality of these parameters correspond respectively to the left (1) and right major sides of the rectangle (3). The value of the examined parameter is reported on the corresponding graduated scale by a marker (point, cross, etc.) (12), put in the position corresponding to numeric value of parameter. Therefore it is possible to carry out a qualitative evaluation of parameter (15). Marker of alterated parameters could be coloured to enhance better altered values. Numeric value and measure unit (11) of the examined parameter are reported in a square (10) consenting a contemporary quantitative evaluation (14).

Description

DESCRIPTION
DEVICE FOR DISPLAYING PARAMETERS IN SUCH A WAY THAT A FAST EVALUATION OF THESE PARAMETERS CAN BE OBTAINED
Technical fields.
This model is applicable in medical field for rapid visualization and evaluation of hematologic parameter, by clinical physician, anaesthetist and surgeon. This model is even applicable in field of engineering and in whatever field in which parameters, measured by numeric values in different scales and measures, should be contemporaneously evaluated.
Background art
By now single hematologic parameter are expressed in numeric values put in a column while range of normality is reported on the right sideexpressed in numeric values
Models are available to report an asterisk near that parameters whose values are out of the range of normality wheteher in defect or in excess
Disclosure of invention.
This model includes parameters evaluated by different measur units and scales of values, reported on different graduated scales [Fig. 5: (13)].
Scales are adapted to- a rectangle (horizontal minor sides, vertical major sides) in a way that inferior and superior limits of normality of these parameters correspond respectively to the left [Fig. 5: (l)]and right major sides of the rectangle [Fig. 5: (3)]
The value of the examined parameter is reported on the corresponding graduated scale by a marker (point, cross, etc) [Fig. 5: (12)], put in the position corresponding to numeric value of parameter.
In this way numeric values are converted in graphic symbols or markers (points, cross, etc): single values are adapted to an unitary pattern that lets the immediate evaluation of that values whether they are normal (inside the rectangle) [Fig. 5: (2)] or they are out of the range of normality (out of the rectangle) [Fig. 5: (5), (7), (9)].
The grade of variation of measured parameter, from inferior or superior normality limits, should be as substantial as marker should be near to left or right limit of scale [Fig. 5: (5), (7)].
Markers of altered parameter could be coloured [Fig.4] to enhance better altered values and to reduce time of examination and evaluation of parameter reported on the model
In medical field this model lets to evaluate which hematological parameters are normal and the ones which are altered with a quick look it's possible to exclude by a more in-depth exam, the normal values put inside colored rectangle [Fig. 5: (2)], and to enhance the altered values in defect (part of the scale to the left of the left major side of the rectangle) [Fig. 5: (9)] or in excess (part of the scale to the right of the right major side of the rectangle) [Fig. 5: (5), (7)] Furthermore it's possible to enhance, by a rapid look, the grade of value alteration of the parameter in exam (minor or major proximity to left or right side of corresponding scale [Fig. 5: (5), (7)].
On the right side there is a square [Fig. 5: (10] in which is precisely reported the numeric value [Fig. 5: (11)] useful for a contemporary quantitative evaluation of the parameter and for forensic medical purposes.
This model is useful in medical field for a rapid visualization and evaluation of hematological parameter:
1) in condition of hospital emergency, reducing time of diagnostic evaluation and intervention; 2) in daily control and updating of hospital ward, during which the physician has to controle 15-20 or more blood tests of different patients by facilitating the physician in reducing time of control and updating of the ward;
3) in medical private field to consent to private institutes, that makes blood tests, to offer another service to his own client whether if he is a physician or a patient;
4) in medical extrahospital private field to consent to physician the evaluation of blood tests of his own patient in a short time;
5) to consent to non-physician patient, who underwent to blood test, to obtain informations, without considering scale values or measur unit, about the rilevation of normal or abnormal values of his hematological parameters and about the grade of this abnormality.
Furthermore the pharmaceutic company which has the exclusive utilizzation of this model could pubblicize it on television contrarily to the reagent used for blood tests. The pharmaceutic company can connect the grant (to pubblic or private companies) to use this model to the one to use their reagents for blood tests by increasing the sales of their reagents.
Brief description of drawings
Fig. 1 is an example of the model for rapid viasualizzation and evaluation of human blood test. Parameters in exam and the abbreviations in the square at the left of the scales are used purely for example. Here we report the abbreviations and the corresponding name of the parameters used only for example in Fig 1
Glyc = glycaemia, Creat = creatinine, Tot Prot = Total Proteins, Album = Albumin, Ammon = seric ammonium, Tot Bil = Total Bilirubin, Conj Bil = 75 Conjugated Bilirubin, Unconj Bil = Unconjugated Bilirubin, AST and ALT = Transaminase, CPK = Creatin- PhosphoKinase, LD = Lactid Dehydrogenase, CHE = Colinesterase, AcPh = Acid Phosphatase, AlPh = Alcalyne Phosphatase, Na = Sodium, K = Potassium, Ca = Calcium
80 Fig. 2 is another example of the model for rapid viasualizzation and evaluation of human blood test Parameters in exam and the abbreviations in the square at the left of the scales are used purely for example Here we report the abbreviations and the corresponding name of the parameters used only for example in Fig 2
MCV = Medium Corpuscolar Volume of erythrocyte, MCH = Medium
85 Coφuscolar Hemoglobin, MCHC = Medium Coφuscolar hemoglobin concentration, Hb = Hemoglobin, Hct = Hematocrit, Neutro = Neutrophilus leukocyte, Eosino = Eosinophilus leukocyte, Baso = Basophilus leukocyte, Linfo = Lynphocyte, Mono = Monocyte, PT = Prothrombine Time, PTT, Partial Thromboplastin Time, TT = Tho bine Time, Fibrin = Fibrinogen, Antitrom III = Antithrombine III
90
Fig.3 shows the application of markers (in this case points) to the model reported in Fig 1 Marker, expressing the value of a parameter, is put on the scale of corresponding parameter and in a position corresponding to its numeric value In the square put on the right is reported the precise numeric value of the parameter, for a
95 contemporary qualitative and quantitative evaluation worth for forensic medical puφose In Fig. 4 markers of altered parameters are coloured to enhance better altered parameter and their values.
100 Fig. 5 (scale 1 : 1) reports explicative notes about Fig. 3 and puts in evidence the advantage of this model. Particolarly it's evident how it's possible to point out, by a quick look, not only normal values (2) or in defect /excess altered values (5), (7), (9), but also values at normality inferior or superior limit (6) (8) and the grade of alteration of alterated parameter (5) (7).. 105
Best mode for carrying out the invention.
Models of rapid visualizzation and evaluation must be printed a part, and distributed to istitutes which perfoms blood tests.
Markers have to be put by a printer connected to a computer: this computer 110 contain a program which convert the numeric value ofan examined parameter, digitated by an operator, in a marker put on a corresponding scale and in a position corresponding to digitated numeric value.
Industrial applicability
115 As reported in the paragraph "Disclosure of invention", the pharmaceutic company which has the exclusive utilizzation of this model could pubblicize it on television contrarily to the reagent used for blood tests. The pharmaceutic company can connect the grant (to pubblic or private companies) to use this model to the one to use their reagents for blood tests by increasing the sales of its reagents. Furthermore
120 the pharmaceutic company could improve the sales of instruments for blood tests.

Claims

1 ) This model includes parameters measured and evaluated by different measure units and scales of values, reported on different graduated scales [Fig. 5: (13)]. Graduated scales are adapted to a rectangle (horizontal minor sides, vertical major sides) in a way that inferior and superior limits of normality of these parameters correspond respectively to the left [Fig. 5: (1)] and right major sides of the rectangle [Fig. 5: (3)].
2) The value of the examined parameter is reported on the corresponding graduated scale by a marker (point, cross, etc) [Fig 5: (12)], put in the position corresponding to numeric value of parameter. Therefore it's possible to carry out a qualitative evaluation of parameter [Fig. 5: (15)].
3) Markers of altered parameter could be coloured [Fig. 4] to enhance better altered values and to reduce time of examination and evaluation of parameter reported on the model.
4) The value of the measured parameter is also reported on the model as a numeric value put in the square [Fig. 5 : ( 10)] to the right of the right limit of graduated scale, in which measure unit is reported too [Fig. 5: (11)]. Therefore it's possible a contemporary quantitative evaluation of the values of the parameter [Fig. 5: (14)]
5) The model adapts parameters, measured in different measure units and scales, to a unitary graphic pattern which permits, by a rapid visualizzation, to identify values inside the range of normality (markers put on the part of the graduated scale inside the rectangle) [Fig. 5: (2)], and to enhance values out of the normality range (marker put on the part of the graduated scale outside the rectangle) [Fig. 5: (5), (7), (9)]: in defect (marker on the part of the graduated scale put on the left of the left side of the rectangle) [Fig. 5: (9)] or in excess (marker put on the part of the graduated scale on the right of the right side of the rectangle) [Fig. 5: (5), (7)].
6) The model consents a rapid qualitative evaluation of grade of alteration of the parameter, in defect or excess (marker on the part of graduated scale put outside the rectangle, at minor or major distance respectively from the left or right side of the rectangle) [Fig.5: (5), (7)]. 7) The model consents to enhance rapidly values at the inferior or superior limit of normality (marker on the inside rectangle part of the graduated scale, at 1-2 millimeters respectively from left or right side of the rectangle).
8) Model consents a contemporary quantitative (numeric values) and qualitative
(markers on graduated scales) evaluation of hematologic parameters in exam. 9) Model is useful in medical and biological fields for rapid visualizzation and evaluation of values of parameters examined in human blood tests, in pubblic or private, hospital or non-hospital fields.
10) Model could be useful in field of engineering ed in whatever field it's necessary to evaluate contemporarly parameters measured by different measur units and scales
PCT/IT1997/0000621996-03-251997-03-19Device for displaying parameters in such a way that a fast evaluation of these parameters can be obtainedWO1997036151A1 (en)

Priority Applications (2)

Application NumberPriority DateFiling DateTitle
AU19391/97AAU1939197A (en)1996-03-251997-03-19Device for displaying parameters in such a way that a fast evaluation of these parameters can be obtained
EP97907270AEP0890082A1 (en)1996-03-251997-03-19Device for displaying parameters in such a way that a fast evaluation of these parameters can be obtained

Applications Claiming Priority (2)

Application NumberPriority DateFiling DateTitle
IT96NA000023IT242561Y1 (en)1996-03-251996-03-25 DEVICE FOR QUICK DISPLAY OF VALUES (HEMATOCHEMICAL AND NON-HEMATOCHEMICAL) ASSESSED ACCORDING TO DIFFERENT UNITS OF MEASUREMENT AND WITH DOSING METHODS
ITNA96U0000231996-03-25

Publications (1)

Publication NumberPublication Date
WO1997036151A1true WO1997036151A1 (en)1997-10-02

Family

ID=11387868

Family Applications (1)

Application NumberTitlePriority DateFiling Date
PCT/IT1997/000062WO1997036151A1 (en)1996-03-251997-03-19Device for displaying parameters in such a way that a fast evaluation of these parameters can be obtained

Country Status (4)

CountryLink
EP (1)EP0890082A1 (en)
AU (1)AU1939197A (en)
IT (1)IT242561Y1 (en)
WO (1)WO1997036151A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US3811040A (en)*1972-09-271974-05-14Gen ElectricVector contour plot of physiological parameters
US4675147A (en)*1983-04-061987-06-23Westinghouse Electic Corp.Generating an integrated graphic display of the safety status of a complex process plant
JPH0382451A (en)*1989-08-251991-04-08Toto LtdHeath data display board

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US3811040A (en)*1972-09-271974-05-14Gen ElectricVector contour plot of physiological parameters
US4675147A (en)*1983-04-061987-06-23Westinghouse Electic Corp.Generating an integrated graphic display of the safety status of a complex process plant
JPH0382451A (en)*1989-08-251991-04-08Toto LtdHeath data display board

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN vol. 15, no. 252 (C - 0844) 26 June 1991 (1991-06-26)*

Also Published As

Publication numberPublication date
ITNA960023V0 (en)1996-03-25
ITNA960023U1 (en)1997-09-25
EP0890082A1 (en)1999-01-13
AU1939197A (en)1997-10-17
IT242561Y1 (en)2001-10-02

Similar Documents

PublicationPublication DateTitle
Dolci et al.Total laboratory automation: do stat tests still matter?
INTERNATIONAL COMMITTEE FOR STANDARDIZATION IN HAEMATOLOGY (ICSH) et al.Protocol for evaluation of automated blood cell counters
WiwanitkitTypes and frequency of preanalytical mistakes in the first Thai ISO 9002: 1994 certified clinical laboratory, a 6–month monitoring
Vallera et al.Accuracy of portable blood glucose monitoring: effect of glucose level and prandial state
PlebaniLaboratory errors: How to improve pre-and post-analytical phases?
Korpi-Steiner et al.Current issues in blood gas analysis
Mooney et al.Point of care testing in general haematology.
Belsey et al.Evaluation of a laboratory system intended for use in physicians' offices: II. Reliability of results produced by health care workers without formal or professional laboratory training
Oliver et al.Real-world use of key performance indicators for point-of-care testing network accredited by ISO 22870
Cembrowski et al.Quality control of automated cell counters
Leichsenring et al.Multicentre ISI assignment and calibration of the INR measuring range of a new point-of-care system designed for home monitoring of oral anticoagulation therapy
Lippi et al.Laboratory testing in pharmacies.
Barth et al.Adjustment of serum total calcium for albumin concentration: effects of non-linearity and of regression differences between laboratories
Nadarajan et al.Use of red blood cell indices for the identification of iron deficiency among blood donors
EP0890082A1 (en)Device for displaying parameters in such a way that a fast evaluation of these parameters can be obtained
Waters et al.A systematic approach to the assessment of erythropoiesis
Delaney et al.Proficiency testing for blood-gas quality control.
MillerPlatelet function testing: an improved approach utilizing lumi-aggregation and an interactive computer system
JP2012108112A (en)Hba1c measurement result display method, display device and display program
LoganEvaluation of commercial kits
Haffer et al.Postcoordination of LOINC Codes in SNOMED CT
GibbEvaluation and assessment of new disposable strip for determination of plasma potassium concentration.
PradellaDivergences between IFCC recommendations for Internal Quality Control and ISO standards
Katz et al.The relationship between INTEM/HEPTEM coagulation time ratio and heparin plasma concentration in obstetric patients: an exploratory in vitro investigation
Cannesson et al.Comment on “Plethysmographic dynamic indices predict fluid responsiveness in septic ventilated patients” by Feissel et al.

Legal Events

DateCodeTitleDescription
AKDesignated states

Kind code of ref document:A1

Designated state(s):AU CA US

ALDesignated countries for regional patents

Kind code of ref document:A1

Designated state(s):AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPERequest for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121Ep: the epo has been informed by wipo that ep was designated in this application
WWEWipo information: entry into national phase

Ref document number:1997907270

Country of ref document:EP

WWPWipo information: published in national office

Ref document number:1997907270

Country of ref document:EP

NENPNon-entry into the national phase

Ref country code:CA

WWWWipo information: withdrawn in national office

Ref document number:1997907270

Country of ref document:EP

DPE2Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)

[8]ページ先頭

©2009-2025 Movatter.jp